16beta-Acetoxy-3beta-[(4-O-beta-D-glucopyranosyl-3-O-methyl-6-deoxy-beta-D-galactopyranosyl)oxy]-14beta-hydroxy-5alpha-card-20(22)-enolide

Details

Top
Internal ID 1e277e97-a13a-44e5-aae9-2126326d93b3
Taxonomy Lipids and lipid-like molecules > Steroids and steroid derivatives > Steroid lactones > Cardenolides and derivatives > Cardenolide glycosides and derivatives
IUPAC Name [(3S,5S,8R,9S,10S,13R,14S,16S,17R)-14-hydroxy-3-[(2R,3R,4R,5S,6R)-3-hydroxy-4-methoxy-6-methyl-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-16-yl] acetate
SMILES (Canonical) CC1C(C(C(C(O1)OC2CCC3(C(C2)CCC4C3CCC5(C4(CC(C5C6=CC(=O)OC6)OC(=O)C)O)C)C)O)OC)OC7C(C(C(C(O7)CO)O)O)O
SMILES (Isomeric) C[C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@H]2CC[C@]3([C@H](C2)CC[C@@H]4[C@@H]3CC[C@]5([C@@]4(C[C@@H]([C@@H]5C6=CC(=O)OC6)OC(=O)C)O)C)C)O)OC)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O
InChI InChI=1S/C38H58O15/c1-17-32(53-34-30(44)29(43)28(42)25(15-39)52-34)33(47-5)31(45)35(49-17)51-21-8-10-36(3)20(13-21)6-7-23-22(36)9-11-37(4)27(19-12-26(41)48-16-19)24(50-18(2)40)14-38(23,37)46/h12,17,20-25,27-35,39,42-46H,6-11,13-16H2,1-5H3/t17-,20+,21+,22+,23-,24+,25-,27+,28-,29+,30-,31-,32+,33-,34+,35+,36+,37-,38+/m1/s1
InChI Key DZDCBMUKBVGLRI-RTNJHBQVSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C38H58O15
Molecular Weight 754.90 g/mol
Exact Mass 754.37757114 g/mol
Topological Polar Surface Area (TPSA) 220.00 Ų
XlogP -0.20
Atomic LogP (AlogP) 0.48
H-Bond Acceptor 15
H-Bond Donor 6
Rotatable Bonds 8

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of 16beta-Acetoxy-3beta-[(4-O-beta-D-glucopyranosyl-3-O-methyl-6-deoxy-beta-D-galactopyranosyl)oxy]-14beta-hydroxy-5alpha-card-20(22)-enolide

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.7964 79.64%
Caco-2 - 0.8873 88.73%
Blood Brain Barrier - 0.6500 65.00%
Human oral bioavailability - 0.6857 68.57%
Subcellular localzation Mitochondria 0.8047 80.47%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.9006 90.06%
OATP1B3 inhibitior + 0.9615 96.15%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior - 0.8750 87.50%
BSEP inhibitior + 0.6340 63.40%
P-glycoprotein inhibitior + 0.7322 73.22%
P-glycoprotein substrate + 0.7218 72.18%
CYP3A4 substrate + 0.7408 74.08%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.9026 90.26%
CYP3A4 inhibition - 0.8841 88.41%
CYP2C9 inhibition - 0.9054 90.54%
CYP2C19 inhibition - 0.9238 92.38%
CYP2D6 inhibition - 0.9467 94.67%
CYP1A2 inhibition - 0.9221 92.21%
CYP2C8 inhibition + 0.5788 57.88%
CYP inhibitory promiscuity - 0.9513 95.13%
UGT catelyzed + 0.8000 80.00%
Carcinogenicity (binary) - 1.0000 100.00%
Carcinogenicity (trinary) Non-required 0.5527 55.27%
Eye corrosion - 0.9892 98.92%
Eye irritation - 0.9219 92.19%
Skin irritation - 0.5611 56.11%
Skin corrosion - 0.9387 93.87%
Ames mutagenesis - 0.6393 63.93%
Human Ether-a-go-go-Related Gene inhibition + 0.7253 72.53%
Micronuclear - 0.7700 77.00%
Hepatotoxicity - 0.6592 65.92%
skin sensitisation - 0.9209 92.09%
Respiratory toxicity + 0.8333 83.33%
Reproductive toxicity + 0.9000 90.00%
Mitochondrial toxicity + 0.6375 63.75%
Nephrotoxicity - 0.8030 80.30%
Acute Oral Toxicity (c) I 0.8305 83.05%
Estrogen receptor binding + 0.8006 80.06%
Androgen receptor binding + 0.7970 79.70%
Thyroid receptor binding - 0.6714 67.14%
Glucocorticoid receptor binding + 0.6502 65.02%
Aromatase binding + 0.6882 68.82%
PPAR gamma + 0.7420 74.20%
Honey bee toxicity - 0.5871 58.71%
Biodegradation - 0.7250 72.50%
Crustacea aquatic toxicity + 0.5100 51.00%
Fish aquatic toxicity + 0.9314 93.14%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 98.98% 91.11%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 98.75% 96.09%
CHEMBL1994 P08235 Mineralocorticoid receptor 95.69% 100.00%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 95.67% 85.14%
CHEMBL1293249 Q13887 Kruppel-like factor 5 95.14% 86.33%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 93.36% 94.45%
CHEMBL3137262 O60341 LSD1/CoREST complex 92.79% 97.09%
CHEMBL5608 Q16288 NT-3 growth factor receptor 91.14% 95.89%
CHEMBL1293277 O15118 Niemann-Pick C1 protein 89.23% 81.11%
CHEMBL241 Q14432 Phosphodiesterase 3A 87.18% 92.94%
CHEMBL3714130 P46095 G-protein coupled receptor 6 86.87% 97.36%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 86.58% 95.89%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 86.28% 94.00%
CHEMBL5255 O00206 Toll-like receptor 4 86.13% 92.50%
CHEMBL2581 P07339 Cathepsin D 84.97% 98.95%
CHEMBL1806 P11388 DNA topoisomerase II alpha 84.41% 89.00%
CHEMBL2111367 P27986 PI3-kinase p110-alpha/p85-alpha 83.78% 94.33%
CHEMBL253 P34972 Cannabinoid CB2 receptor 82.81% 97.25%
CHEMBL4303 P08238 Heat shock protein HSP 90-beta 81.62% 96.77%
CHEMBL1075094 Q16236 Nuclear factor erythroid 2-related factor 2 81.48% 96.00%
CHEMBL5028 O14672 ADAM10 81.12% 97.50%
CHEMBL1937 Q92769 Histone deacetylase 2 80.15% 94.75%

Cross-Links

Top
PubChem 101632317
NPASS NPC85051
LOTUS LTS0044493
wikiData Q104991742